Morgan Stanley Maintains Underweight on Helmerich & Payne, Raises Price Target to $41
Morgan Stanley analyst Joe Laetsch maintains Helmerich & Payne (NYSE:HP) with a Underweight and raises the price target from $36 to $41.
Read original at benzingaStocks · News reference
Helmerich & Payne Q3 Adj. EPS $(0.11) Misses $0.13 Estimate, Sales $1.034B Beat $988.740M Estimate
Helmerich & Payne (NYSE:HP) reported quarterly losses of $(0.11) per share which missed the analyst consensus estimate of $0.13 by 184.62 percent. This is a 150 percent decrease over earnings of $0.22 per share from
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 5, 2026, 8:18 PM
- Checked
- Aug 5, 2026, 8:18 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Shares of oil and gas engineering and services companies are trading higher amid crude price gains due to continued Iranian demands over war reparations, unfreezing of sanctioned assets, and Strait of Hormuz tolling as negotiations with the U.S. may have reached an impasse.
Read original at benzingaVarex Imaging Posts Upbeat Q3 Earnings, Joins Bowman Consulting, MarineMax And Other Big Stocks Moving Higher On Monday
BWMN gained 55.1%, HZO rose 45.8%, ABCL gained 35.6%, SLN rose 34.3%, ACHR gained 19.5%, NESR gained 16.4%, AQST gained 15.4%, STDN rose 13.7%.
Read original at benzingaBarclays Maintains Overweight on Helmerich & Payne, Raises Price Target to $50
Barclays analyst Eddie Kim maintains Helmerich & Payne (NYSE:HP) with a Overweight and raises the price target from $47 to $50.
Read original at benzinga